William Blair Shuffles Analyst Conviction List for April 2026 Apr 1, 2026 07:15AM
William Blair on Dianthus Therapeutics (DNTH): FDA removing ANA criteria 'an incremental positive' Mar 26, 2026 10:54AM
William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): 'should see multiple value inflection for shares' Mar 16, 2026 10:09AM
Dianthus Therapeutics completes $719 million public offering Mar 12, 2026 04:01PM
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Mar 12, 2026 04:01PM


Mar 10, 2026 10:54PM Dianthus Therapeutics prices $625 million public stock offering
Mar 10, 2026 10:54PM Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
Mar 9, 2026 04:01PM Dianthus Therapeutics announces $400 million public stock offering
Mar 9, 2026 04:01PM Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
Mar 9, 2026 08:11AM William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): "remain bullish here"
Jul 2, 2025 06:02AM William Blair Starts Dianthus Therapeutics (DNTH) at Outperform